http://ift.tt/eA8V8J
DIJON, France–(BUSINESS WIRE)–Regulatory News: ONCODESIGN (Paris:ALONC) (FR0011766229 – ALONC), a biotechnology company serving the pharmaceutical industry in the discovery of new therapeutic molecules to fight cancer and other serious illnesses with no known effective treatment, has announced the opening of a period of exclusive negotiations to acquire Bertin Pharma’s service businesses in Metabolism, Pharmacokinetics, Bio-analysis and Translational Medicine. These activities in the fields o
May 10, 2017 at 09:35PM
from
No comments:
Post a Comment